Publications

Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery : An International Randomized Controlled Trial.

Marcucci M

Ann Intern Med. 2023 Apr 25;176(5):605-614. doi: 10.7326/M22-3157

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

Weinreb I

Nat Genet. 2014 Sep 21;46(11):1166-9. doi: 10.1038/ng.3096

Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6.

Sammarco G

Cells. 2019 Sep 12;8(9)doi: 10.3390/cells8091074

High-Resolution Analysis of Mononuclear Phagocytes Reveals GPNMB as a Prognostic Marker in Human Colorectal Liver Metastasis.

Cortese N

Cancer Immunol Res. 11(4):405-420. doi: 10.1158/2326-6066.CIR-22-0462

hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.

Trono P

J Immunother Cancer. 11(8)doi: 10.1136/jitc-2023-006913

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

Castagna L

Bone Marrow Transplant. 2017 Jan 16;52(5):683-688. doi: 10.1038/bmt.2016.348

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Castagna L

Bone Marrow Transplant. 2015 Jan 26;50(4):499-504. doi: 10.1038/bmt.2014.304

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.

Necchi A

Ann Oncol. 2014 Oct 24;26(1):167-172. doi: 10.1093/annonc/mdu485

Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

Lavazza C

Blood. 2010 Jan 14;115(11):2231-40. doi: 10.1182/blood-2009-08-239632

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

Dodero A

Blood. 2009 Feb 11;113(19):4771-9. doi: 10.1182/blood-2008-10-183723